JMIR Publication

Clinical study finds that offering digital health platform Cardihab increases participation in cardiac rehabilitation

18th January, 2022

A clinical study of patients with cardiovascular disease by Queensland Cardiovascular Group has found that offering a digital health platform,…

Read More
A year of change, letter from the CEO

Digitising Cardiac Care: A year of change – more for the better

16th December, 2021

Our inspiration and motivation comes from the people whose lives we help change. We all hoped we would be rejoicing…

Read More
AndHealth+ Accelerator cohort

Cardihab selected as part of the $20M ANDHealth+ Digital Health Accelerator cohort

9th December, 2021

Australia’s only not-for-profit digital health commercialisation organisation, ANDHealth today announced that Cardihab has been selected to take part in its Medical Research Future Fund (MRFF) funded ANDHealth+ program.

Read More

Digital health startup Cardihab is changing clinical care for people with cardiac disease

8th December, 2021

Australian digital health startup Cardihab is changing the lives of thousands of people with cardiac disease – the world’s biggest killer.

Read More

Digital health is changing the future of cardiac care

29th October, 2021

Digital health is bringing new solutions that are transforming the lives of thousands of people with cardiac disease.

Read More
AstraZeneca and Slush

Cardihab joins the discussion with AstraZeneca and Slush on the next generation of healthcare

21st October, 2021

In October 2021, AstraZeneca and Slush joined forces with a few start-ups and entrepreneurs for a collaborative event providing a…

Read More

Digital care post-covid: not a tsunami, just a big wave

8th October, 2021

Countless new health tech innovations may have popped up over the past two years, but has it been enough to overcome hesitancy toward telehealth.

Read More
Cardihab being used in a world leading long COVID study

Cardihab being used in a world leading long COVID study

4th August, 2021

Today the Baker Heart and Diabetes Institute announced a world leading investigation into the long-term heart damage caused by COVID-19.

Read More
ImpaQT Group's support and investment in Cardihab

Cardihab are delighted to have ImpaQT Group investment

26th July, 2021

We are delighted to have the ImpaQT Group’s support and investment to help us to fulfil our mission of improving access to care for patients recovering from cardiac events and/or living with heart disease.

Read More

The Baker Institute and Cardihab collaborate to deliver new digital heart disease prevention and management approaches

26th July, 2021

Digital health will take transformative steps by supporting new clinical trials to address secondary prevention of Australia’s deadliest disease following an agreement between Australian digital health company Cardihab and medical research organisation, the Baker Heart and Diabetes Institute.

Read More
Cardihab, Baker Institute to study the effectiveness of digital health approaches to cardiac rehabilitation

In The News – Cardihab, Baker Institute to study the effectiveness of digital health approaches to cardiac rehabilitation

23rd July, 2021

Read how Cardihab and Baker Heart and Diabetes Institute, a medical research organisation in Melbourne, have signed a five-year agreement to jointly conduct clinical trials and cohort studies.

Read More
How digital solutions to cardiac rehabilitation are transforming patient outcomes webinar

Webinar recording: How digital solutions to cardiac rehabilitation are transforming patient outcomes

8th July, 2021

The webinar hosted by Australian Healthcare and Hospitals Association (AHHA) is now available to watch.

Read More